Commentary: Republican action threatens to raise health care premiums lowered by the Inflation Reduction Act
In a twist of fate, I was advocating for accessible health care when I first felt pain in my left breast. Like many women, ...
Ludlow Solar Project gets $2.3 million from Inflation Reduction Act
MMWEC said Monday it believes it is one of the first public power joint action agencies to benefit from this clean energy tax ...
IRS has improved taxpayer services but is slow to resolve ID theft, an independent watchdog says
The IRS boosted taxpayer services through Democrats’ Inflation Reduction Act but still faces processing claims from a ...
Retirement Daily on The Street on MSN2h
New AARP Report: Top Medicare Part D Drugs See Average Lifetime Price Hike of 98%
Findings show the impact of drug companies’ relentless price increases, underscoring the importance of the changes included ...
Hosted on MSN6d
How To Save on Green Improvements Under Inflation Reduction Act
Tax credits for energy-efficient home improvements are extended and expanded by the Inflation Reduction Act. Wayne Osmond, ...
Biden Energy Secretary: Hit reverse on EV investments and China wins the race
The EV tax credit, designed to help America lead in one of the world’s fastest-growing markets, should be preserved.
Biden administration achieves fourth record-breaking ACA enrollment ahead of exit
The Biden administration has achieved a fourth consecutive record year in HealthCare.gov Marketplace enrollment, one week ...
Taxpayer Advocate urges Congress to preserve IRS funding for service, technology
The National Taxpayer Advocate has urged Congress to preserve IRS funding for taxpayer service and technology amid Republican scrutiny.
Medicare out-of-pocket cap on prescriptions takes effect
More than 70,000 seniors in Washington state will save hundreds or thousands of dollars each year thanks to the new annual cap on out-of-pocket prescription drug costs for folks on Medicare Part D, ...
Ozempic, Trulicity among Medicare's priciest drugs, report finds
Novo Nordisk expects Ozempic, which has been on the market since 2017, will be on Medicare's list of drugs to negotiate ...